Skip to main content
Premium Trial:

Request an Annual Quote

Congenica Receives CE Mark for Clinical Decision Support Software

NEW YORK – Congenica said Wednesday that it has obtained CE-IVD marking for its genomic data analysis and clinical decision support technology.

The Cambridge, UK-based company makes a modular and scalable data analytics tool for annotating and clinically interpreting genomic sequence data to support clinical decision-making. The CE designation allows Congenica to apply its software to clinical diagnosis of rare hereditary disorders.

"This is a significant milestone for Congenica as we expand into new markets as part of the ongoing international rollout of our software platform," CEO David Atkins said in a statement. "With the CE mark designation, our customers can now use our product for the diagnosis of genetic diseases as part of standard care, bringing us closer to our vision of genomic medicine being routinely incorporated into clinical practice at a global scale."

Indeed, Congenica has been widening its global footprint this year. In April, the firm entered into a partnership with Camtech Diagnostics to market and distribute its software in Singapore, Malaysia, Japan and South Korea. A month earlier, the company announced a distribution agreement with Amplitech to distribute its products in France and other French-speaking European countries. 

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.